Obsidian Therapeutics Inc.
Organization details
- Legal name
- Obsidian Therapeutics Inc.
- Former names
- Gazelle Parent, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OBX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002130606
- EIN
- 42-1977778
Board of directors
-
Heidi Hagen · DirectorSince 2026
-
Madan Jagasia · Director · Chief Executive OfficerSince 2026
-
Maria Fardis · DirectorSince 2026
-
Matthew Norkunas · DirectorSince 2026
-
Peter Barrett · DirectorSince 2026
-
Robert W. Ross · DirectorSince 2026
Chief executives
Board connections
4 of this board's directors also sit on 4 other boards. 3 are in the same sector.
-
CRISPR Therapeutics AG Same sectorvia Maria Fardis
- via Peter Barrett
-
Vericel Corporation Same sectorvia Heidi Hagen
-
Xilio Therapeutics Inc. Same sectorvia Robert W. Ross
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Obsidian Therapeutics Inc.
Who is the CEO of Obsidian Therapeutics Inc.?
Madan Jagasia has been Obsidian Therapeutics Inc.'s Chief Executive Officer since August 2026.
How many directors are on Obsidian Therapeutics Inc.'s board?
Obsidian Therapeutics Inc.'s board has 6 directors: Heidi Hagen, Madan Jagasia, Maria Fardis, Matthew Norkunas, Peter Barrett and Robert W. Ross.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="obsidian-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.